Biopharma CMO Appoints Chief Business Officer

Rentschler Biotechnologie has announced the appointment of Frank Ternes to the position of Chief Business Officer, effective 1 February 2013. In this position, Ternes will contribute to the success of the organisation by leading the planning, development and execution of all business development, sales and marketing and project management activities.

"Mr. Ternes is an excellent addition to Rentschler's management board," said Dr. Nikolaus F. Rentschler, CEO and owner of Rentschler. "With his broad experience in the contract manufacturing business, he has a keen understanding of technology, a strong customer focus, and a proven track record for achieving success.”

Ternes brings more than 25 years of experience from Operations and Technology at Boehringer Ingelheim where he last served as Senior Vice President of Biopharmaceutical Contract Manufacturing.

Ternes holds a degree equivalent to a master’s degree in economics from the University of Bonn, Germany.

Rentschler Biotechnologie GmbH, +49 7392 701 478, friederike.braun@rentschler.de, www.rentschler.de/en.